Medicine

The cost of generic drugs for many people could go up if President-elect Donald Trump follows through on his promise to impose sweeping tariffs on products from China and other foreign countries, policy experts say.

A clinical trial is testing whether an existing drug could benefit patients with Alzheimer’s disease, in hopes of making symptom-improving medication more accessible for people experiencing mild cognitive impairment.

After spending nearly a year at Children’s Hospital of Philadelphia, conjoined twins Amari and Javar Ruffin were successfully separated.

Forty years after the Hatch-Waxman Act created a market for affordable generic versions of prescription medications, it is struggling with persistent shortages.

Is Novo Nordisk helping Americans save taxpayer money or ripping them off? The company’s CEO is scheduled to testify Tuesday on Capitol Hill.

The late-stage trial on tirzepatide also found that patients experienced sustained weight loss over the roughly three-year treatment period.

Federal regulators on Tuesday sent warning letters to several drugmakers, taking issue with patents on popular drugs for weight loss, diabetes, asthma and other respiratory conditions.

President Joe Biden often overstates what people who are eligible for the price cap for insulin paid previously.

A doctor who was once a good fit might not always meet the needs you have now. Here are some signs that it’s time to find a new one.

A drug company is recalling some of its ADHD and narcolepsy medication because the bottles may contain the wrong pills inside. The U.S. Food and Drug Administration said in a notice published last week that Azurity Pharmaceuticals is recalling one lot of Zenzedi 30-milligram dextroamphetamine sulfate tablets. The move comes after a pharmacist in Nebraska found carbinoxamine maleate tablets,...

A growing number of states are offering dental care to low-income adults who once had to rely on charity or the emergency room to treat their tooth problems.

After the Supreme Court struck down affirmative action in college admissions, concerns have arisen that a pathway into medicine may become much harder for students of color. Heightening the alarm: the medical field’s reckoning with longstanding health inequities.

A medical device the size of a dinner plate was left inside a woman’s abdomen for 18 months.

A neurosurgeon investigating a woman’s mystery symptoms in an Australian hospital has plucked an 8-centimeter (3-inch) wriggling worm from the patient’s brain.

New York surgeons transplanted a pig’s kidney into a brain-dead man and for over a month it’s worked normally.

Some private insurers are balking at paying for the first drug fully approved to slow mental decline in Alzheimer’s patients.

More than 70 years after doctors at Johns Hopkins Hospital took Henrietta Lacks’ cervical cells without her knowledge, a lawyer for her descendants said they have reached a settlement with a biotechnology company they sued in 2021, accusing its leaders of reaping billions of dollars from a racist medical system.

U.S. health advisers are backing the full approval of an Alzheimer’s drug that received preliminary approval last year. A panel of advisers to the Food and Drug Administration on Friday voted in favor of the infused medication from drugmakers Eisai and Biogen. The FDA granted accelerated approval in January based on early results suggesting the drug could modestly slow Alzheimer’s....